Regeneron is a biotechnology company that develops and markets medicines and therapies for serious diseases.
No entity score yet. This entity needs at least one linked article with an entity impact vote and focus support.
Showing 1-1 of 1 linked article
Page 1 of 1
Regeneron won FDA approval for the first gene therapy for a rare genetic hearing loss, and the company says it will provide the treatment free to U.S. patients.
Per-entity impact from this article: None